Insights

Gathering insights about Agio…

Similar companies to Agio

Agio Tech Stack

Agio uses 8 technology products and services including Kubernetes, Cloudflare, Selenium, and more. Explore Agio's tech stack below.

Kubernetes
Containerization
Cloudflare
Content Management System
Selenium
Frameworks And Libraries
Spring Boot
Frameworks And Libraries
Kotlin
Programming Languages
PHP
Programming Languages
Quintiq
Supply Chain Management
Microsoft ASP.NET
Web Frameworks

Media & News

Analysts Set Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Price Target at $57.25
Shares of Agios Pharmaceuticals, Inc. (NASDAQ: AGIO - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation
Nov 04, 2025 | www.defenseworld.net
Q3 2025 Highlights - Agios Posts Strong Pyrukynd Revenue And Eyes FDA Milestones
Agios Pharmaceuticals delivered strong Q3'25 results, with revenue up 44% year-over-year and continued momentum in its rare-disease pipeline. AGIO's key catalysts include the FDA decision on Pyrukynd's thalassemia sNDA in December 2025 and topline data from the 'RISE UP' sickle cell trial. Despite premium valuation, the company maintains a robust balance sheet and is positioned for significant growth if regulatory approvals and market expansion materialize.
Nov 04, 2025 | seekingalpha.com
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on mitapivat, an oral pyruvate kinase (PK) activator, will be featured in oral and poster presentations during the 67th American Society of Hematology (ASH) Annual Meeting and Exposition (ASH 2025) in Orlando, Florida, December 6-9, 2025.
Nov 03, 2025 | www.globenewswire.com
AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues
Agios posts a narrower-than-expected third-quarter loss as Pyrukynd drives a 44% revenue rise, with potential label expansions on the horizon.
Oct 31, 2025 | www.zacks.com
Agios Pharmaceuticals, Inc. (AGIO) Q3 2025 Earnings Call Transcript
Agios Pharmaceuticals, Inc. ( AGIO ) Q3 2025 Earnings Call October 30, 2025 8:00 AM EDT Company Participants Morgan Sanford Brian Goff - CEO & Director Cecilia Jones - Chief Financial Officer Tsveta Milanova - Chief Commercial Officer Sarah Gheuens - Chief Medical Officer and Head of Research & Development Conference Call Participants Eric Schmidt - Cantor Fitzgerald & Co., Research Division Alec Stranahan - BofA Securities, Research Division Marc Frahm - TD Cowen, Research Division Tessa Romero - JPMorgan Chase & Co, Research Division Presentation Operator Good morning, and welcome to Agios Pharmaceuticals Third Quarter 2025 Conference Call. [Operator Instructions] Please be advised that this call is being recorded at Agios' request.
Oct 30, 2025 | seekingalpha.com
Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Beats Revenue Estimates
Agios Pharmaceuticals (AGIO) came out with a quarterly loss of $1.78 per share versus the Zacks Consensus Estimate of a loss of $1.93. This compares to earnings of $4.2 per share a year ago.
Oct 30, 2025 | www.zacks.com
Agios Reports Third Quarter 2025 Financial Results and Provides Business Update
$12.9 million in third quarter PYRUKYND® (mitapivat) net revenues PDUFA goal date for PYRUKYND U.S. sNDA in thalassemia set for December 7, 2025 CHMP adopted positive opinion for PYRUKYND in thalassemia; EC decision expected by early 2026 RISE UP Phase 3 trial topline results in sickle cell disease by year-end; potential U.S. commercial launch in 2026 Phase 2b tebapivat trial in lower-risk MDS fully enrolled; topline results expected in early 2026 $1.3 billion dollars in cash, cash equivalents and marketable securities as of September 30, 2025 CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced financial results and updates for the third quarter ended September 30, 2025.
Oct 30, 2025 | www.globenewswire.com

Agio's Email Address Formats

Agio uses at least 1 format(s):

Agio Email Formats	Example	Percentage
First.Last@agio.se	John.Doe@agio.se	50%
First.Last@agio.se	John.Doe@agio.se	50%

Frequently Asked Questions

Where is Agio's headquarters located?

Agio's main headquarters is located at Västra Varvsgatan 3, PL 3 LULEÅ, 972 36, SE. The company has employees across 1 continents, including Europe.

What is Agio's phone number?

You can contact Agio's main corporate office by phone at

+46-920-22-5****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Agio's stock symbol?

Agio is a publicly traded company; the company's stock symbol is AGIO.

What is Agio's official website and social media links?

Agio's official website is agio.se and has social profiles on LinkedIn.

What is Agio's NAICS code?

Agio's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does Agio have currently?

As of October 2025, Agio has approximately 71 employees across 1 continents, including Europe. Key team members include Ceo: L. F. J.Chairman: O. B.Manager: J. W.. Explore Agio's employee directory with LeadIQ.

What industry does Agio belong to?

Agio operates in the IT Services and IT Consulting industry.

What technology does Agio use?

Agio's tech stack includes KubernetesCloudflareSeleniumSpring BootKotlinPHPQuintiqMicrosoft ASP.NET.

What is Agio's email format?

Agio's email format typically follows the pattern of First.Last@agio.se. Find more Agio email formats with LeadIQ.

When was Agio founded?

Agio was founded in 2003.

Agio

Q: What is Agio's official website and social media links?

Agio's official website is agio.se. Agio has social profiles on LinkedIn.

Q: How many employees does Agio have currently?

Agio has approximately 71 employees.

Q: What technology does Agio use?

Agio's tech stack includes Microsoft IIS, GDPR, ESRI, Microsoft 365, Google Analytics.

IT Services and IT ConsultingSweden51-200 Employees

Agio är experter på att skapa effektivare verksamhetsprocesser, där IT och verksamhet tillsammans ger kunden en säker väg till framgång. 
Vi levererar med engagemang, kunskap och ansvar. Vi ger alltid 100% för att uppnå effektivare processer.  
Vår bas är inom dokument- och ärendehantering, beslutsstöd och produktions- och logistiksystem. Vi erbjuder tjänster inom verksamhetsutveckling, projektledning och systemutvecklingsprocessens olika roller.